Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-04-21

Clinical Trial Update: Platinum Chemotherapy Plus Paclitaxel With Bevacizumab and Atezolizumab in Metastatic Carcinoma of the Cervix [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating platinum-based chemotherapy plus paclitaxel with bevacizumab and atezolizumab in metastatic cervical cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Atezolizumab (atezolizumab)
  • Bevacizumab (bevacizumab)
  • PACLITAXEL (PACLITAXEL)
  • Platinum-based chemotherapy (platinum-based chemotherapy)

Snippet

Sponsor: Grupo Español de Investigación en Cáncer de Ovario | Conditions: Carcinoma of the Cervix, Stage IVB | Phase 3 | Status: COMPLETED